Microscopic Polyangiitis

Microscopic Polyangiitis (MPA) is a systemic, necrotizing small-vessel vasculitis characterized by a lack of significant immune complex deposition (pauci-immune). It primarily affects the kidneys and lungs, frequently leading to rapidly progressive glomerulonephritis and pulmonary capillaritis.

The exact cause remains idiopathic. It is classified as an autoimmune condition where the immune system attacks small blood vessels. Environmental triggers, such as silica dust or specific drugs (e.g., hydralazine, propylthiouracil), have been associated with its onset. Genetic predisposition involves HLA-DR subtypes, though no singular causative gene exists.

MPA is driven by antineutrophil cytoplasmic antibodies (ANCA), primarily directed against myeloperoxidase (MPO). These antibodies activate neutrophils, causing them to adhere to the vascular endothelium, degranulate, and release reactive oxygen species and proteolytic enzymes. This leads to vessel wall necrosis, fibrinoid deposits, and end-organ ischemia, notably in the glomeruli and pulmonary microvasculature.

MPA is rare, with an annual incidence of 2–10 per million. It typically presents in the 5th to 6th decade of life. There is a slight male predominance, and it is more common in Caucasians than Asian populations.

Age (older than 50), prior exposure to silica, chronic infections, and specific medications (hydralazine, levamisole-tainted cocaine).

A. Early Symptoms
Fatigue, fever, weight loss, myalgia, arthralgia. B. Common Symptoms
Hematuria, proteinuria, hypertension, dyspnea, cough. C. Advanced Symptoms
Hemoptysis, pulmonary hemorrhage, renal failure, peripheral neuropathy (mononeuritis multiplex). D. Emergency Symptoms
Severe hemoptysis, oliguria/anuria (acute kidney injury), respiratory distress, acute mental status changes.

Pallor, peripheral edema, bibasilar crackles on auscultation, palpable purpura, hypertension, evidence of skin ulcers or gangrene.

A. Clinical Assessment: History of systemic inflammatory symptoms combined with renal or pulmonary decline.
B. Laboratory Testing: Serology for MPO-ANCA.
C. Imaging Studies: High-resolution CT (HRCT) for pulmonary involvement.
D. Functional Tests: Pulmonary function tests (DLCO).
E. Biopsy Findings: Renal biopsy showing pauci-immune necrotizing glomerulonephritis.
F. Genetic Testing: Generally not indicated.
G. Differential Diagnosis: Granulomatosis with polyangiitis (GPA), Goodpasture syndrome, IgA vasculitis.

Test Name: MPO-ANCA
Type: Blood Test
Purpose: Diagnostic screening for AAV
Expected Findings: Positive (p-ANCA pattern)
Interpretation: Highly specific for MPA Test Name: Urinalysis
Type: Urine Test
Purpose: Evaluate renal involvement
Expected Findings: Hematuria, red cell casts, proteinuria
Interpretation: Suggests glomerulonephritis

HRCT: Used to detect ground-glass opacities (alveolar hemorrhage) or fibrosis.
Chest X-ray: Used to exclude infectious causes of lung infiltrates.

Granulomatosis with polyangiitis (lack of granulomas in MPA), Goodpasture syndrome (Anti-GBM antibodies present), Systemic Lupus Erythematosus.

End-stage renal disease (ESRD), chronic lung fibrosis, treatment-related infections, secondary malignancies.

A. Lifestyle Modifications: Smoking cessation, hypertension management.
B. Preventive Measures: Vaccination against influenza/pneumonia, bone protection (bisphosphonates).
C. Medical Treatment:

• Induction: Rituximab or Cyclophosphamide plus Glucocorticoids.


• Maintenance: Rituximab or Azathioprine.

Historically fatal; with current immunosuppressive therapy, the 5-year survival rate is 70–80%. Prognosis depends heavily on the degree of renal impairment at diagnosis.

No primary prevention. Secondary prevention involves close monitoring for relapse via serial ANCA titers and urine protein levels.

The following homeopathic remedies have been historically indicated for symptoms associated with Microscopic Polyangiitis. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Microscopic Polyangiitis.